Mkts

Alnylam Pharmaceuticals, Inc.

NASDAQ: ALNY
$159.85+8.21 (+5.41%)
As of Nov 11, 4:00 PM ET

Key statistics

Day range
151.85159.92
52-week range
149.18479.79
Today
Open152.22
Previous close159.85
Volume785.4K
Valuation
Market cap20.31B
P/E ratio7.46×
EPS (TTM)19.75
Income & risk
Dividend / yield—
Beta0.46
Avg volume2.04M
Discussion

ALNY News

Stories mentioning ALNY from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30Q1 '24Mar 31
Income Statement
Revenue1,097,0331,249,026773,689594,189593,166500,919659,825494,333
Cost of Goods Sold267,723197,231142,02970,183102,64981,98067,27154,613
Gross Profit829,3101,051,795631,660524,006490,517418,939592,554439,720
Operating Expenses
Research & Development372,218358,814323,621265,122300,169270,926294,142260,995
Sales General & Admin325,374322,076323,314239,949295,339220,993248,397210,797
Total Operating Expenses
Operating Income (Loss)131,718367,982(16,199)18,077(105,159)(76,905)48,614(43,435)
Interest Income26,63028,68127,48628,67331,01932,14629,18229,645
Interest Expense35,253
Other Expense76,562(74,150)(6,399)9,191(80,847)(29,528)(55,705)(14,544)
Pretax Income121,909238,969(35,358)(2,368)(193,958)(108,663)(11,167)(63,587)
Tax Provision(25,282)(12,115)30,91915,883(110,195)2,9075,7222,348
Net Income (Loss)147,191251,084(66,277)(18,251)(83,763)(111,570)(16,889)(65,935)
Earnings Per Share (Basic)1.121.91(0.51)(0.14)(0.66)(0.87)(0.13)(0.52)
Earnings Per Share (Diluted)1.091.84(0.51)(0.14)(0.66)(0.87)(0.13)(0.52)
Weighted Average Shares Outstanding (Basic)131,004131,447130,628129,676127,651128,590126,733126,138
Weighted Average Shares Outstanding (Diluted)134,684137,348130,628129,676127,651128,590126,733126,138

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ALNY

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is a stock listed on the Nasdaq Stock Market under the ticker symbol ALNY. It last traded at $159.85 (Nov 11, 2026, 4:00 PM ET), up 5.4% on the day. That gives Alnylam Pharmaceuticals a market capitalisation of $20.3B and a price-to-earnings ratio of 7.5.

Over the past 52 weeks ALNY has traded between $149.18 and $479.79.

Revenue for the quarter ended Dec 31, 2025 was $1.1B; net income $147.2M. Revenue was up 84.9% from $593.2M in the quarter ended Dec 31, 2024.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Dec 31, 2025$1.1B$147.2M13.4%
Sep 30, 2025$1.2B$251.1M20.1%
Jun 30, 2025$773.7M-$66.3M-8.6%
Mar 31, 2025$594.2M-$18.3M-3.1%

From Alnylam Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…